NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
- Response deadline
- May 25, 2029 Due in 996 days
- Date posted
- May 7, 2026
- Source
- Open notice
Description
This notice of funding opportunity (NOFO) invites submission of investigator-initiated Program Project (P01) applications. The proposed Programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each application submitted to this NOFO must include at least two related, synergistic Research Projects that share a common central theme, focus, and/or overall objective; and an Administrative Core. An application may include Scientific Core(s), if needed for the proposed research.
Classifications
- NAICS93.855
Documents (1)
- DownloadPAR-27-082-Full-Announcement.htmltext/html;charset=UTF-8153 KB
Contacts
Similar contracts
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)Due Sep 24, 2026
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)Due Jul 1, 2028
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)Due Jul 5, 2029
- Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)Due Jul 12, 2029
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)Due May 25, 2029
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)Due Nov 5, 2028